NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED
SECURITIES

The null hereby notifies the SEC of its intention to remove the entire
class of the stated securities from listing and registration on the
Exchange at the opening of business on September 10, 2013, pursuant
to the provisions of Rule 12d2-2 (a).

[  X  ] 17 CFR 240.12d2-2(a)(3)  That on August 29, 2013 the
instruments representing the securities comprising the entire class
of this security came to evidence, by operation of law or otherwise,
other securities in substitution therefore and represent no other right
except, if such be the fact, the right  to receive an immediate cash
payment.

The merger between PROLOR Biotech, Inc. and OPKO Health, Inc. became
effective on August 29, 2013.  Each share of Common Stock of PROLOR
Biotech, Inc. was converted into 0.9951 of a share of Common Stock
of OPKO Health, Inc.

The Exchange also notifies the Securities and Exchange Commission that
as a result of the above indicated conditions this security was
suspended from trading on August 30, 2013.